The Vytorin Controversy: What’s a Patient to Do? This post was originally published on May 15, 2008 and updated updated on January 16, 2009. Click here to read the update.
/18/2008Researchers Debate Ezetimibe (Vytorin) ENHANCE Trial -Part 3 Controversy over the ENHANCE trial continued despite lengthy dubbi su Vytorin
FDA Investigating Link between Vytorin and Cancer August 22, 2008 This has caused a great deal of controversy, as Zetia and Vytorin are widely used,
Learn about Vytorin (Ezetimibe and Simvastatin) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
A new combination tablet containing simvastatin plus ezetimibe is expected to become a new mainstream player in the cholesterol market, but some are concerned about the lack of outcome data with the product.
The cholesterol lowering drug Vytorin and its parent companies Merck and Schering-Plough This controversy stems from the long awaited and Vytorin Injuries.
CBS/AP) Patients with chronic kidney disease often face other problems, including heart failure and stroke. Vytorin to the rescue? The FDA says Merck's popular cholesterol drug helps reduce cardiovascular problems in patients with kidney disease and found no new safety concerns with the drug
After a study two weeks ago showed that the blockbuster cholesterol drug Vytorin did controversy by taking on cholesterol a controversy where
What would a new year be without a full-blown pharmaceutical controversy? Last summer there were black-box warnings for Avandia and …
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VYTORIN safely and effectively. See …
Talk to your doctor before you start taking any new medicines. Taking VYTORIN with certain other medicines may affect each other causing side
Vytorin, a cholesterol fighting drug, may not be effective at preventing heart attacks and strokes.
I just took a peek at a controversy raging in another pharmaceutical field, which put our discussion here into interesting perspective. The new controversy in t. . .
Ezetimibe (Vytorin, Zetia) reduces cholesterol levels reliably, but its appropriate place in the treatment of cholesterol is still controversial.
VYTORIN (Ezetimibe,Simvastatin) drug information patient assistance.